Netherlands (NL)

Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis. (2022) Kerick M, Acosta-Herrera M, Pilar Simeon-Aznar C, Luis Callejas J, Assassi S, Proudman SM, Nikpour M, et al. Journal article Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. (2022) Cavagna L, Meloni F, Meyer A, Sambataro G, Belliato M, De Langhe E, Cavazzana I, et al. Journal article The Physical Activity Environment Policy Index (PA-EPI): a Tool for Monitoring and Benchmarking Government Policies Promoting Physical Activity (2022) Woods CB, Kelly L, Volf K, Gelius P, Messing S, Forberger S, Lakerveld J, et al. Conference contribution, Abstract of lecture Identification of de novo variants in nonsyndromic cleft lip with/without cleft palate patients with low polygenic risk scores (2022) Ishorst N, Henschel L, Thieme F, Drichel D, Sivalingam S, Mehrem SL, Fechtner AC, et al. Journal article Prognostic Significance of Nonobstructive Left Main Coronary Artery Disease in Patients With and Without Diabetes: Long-Term Outcomes From the CONFIRM Registry (2022) Lee J, Shaikh K, Nakanishi R, Gransar H, Achenbach S, Al-Mallah MH, Andreini D, et al. Journal article Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. (2022) Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, Bauer JM, et al. Journal article Test–retest precision and longitudinal cartilage thickness loss in the IMI-APPROACH cohort (2022) Wirth W, Maschek S, Marijnissen AC, Lalande A, Blanco FJ, Berenbaum F, van de Stadt LA, et al. Journal article Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study (2022) Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, et al. Journal article QUASILINEAR-TIME COMPUTATION OF GENERIC MODAL WITNESSES FOR BEHAVIOURAL INEQUIVALENCE (2022) Wißmann T, Milius S, Schröder L Journal article Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment. (2022) Garbe C, Keim U, Amaral T, Berking C, Eigentler TK, Flatz L, Gesierich A, et al. Journal article